To address this issue, we crossed Gan (K19-Wnt1/C2mE transgenic) mice, a gastric cancer mouse model, and p53-deficient mice to generate p53+/+ Gan, p53+/− Gan and p53−/− Gan mice. Here, KRT19 is linked to gastric cancer.